BeOne Medicines (ONC)
NASDAQ:ONC
Want to see ONC full AI Analyst Report?
BeOne Medicines (ONC) Ownership Overview
59.67% Insiders
11.88% Mutual Funds
21.97% Other Institutional Investors
0.95% ETFs
5.53% Public Companies and
Individual Investors
The ownership structure of BeOne Medicines (ONC) stock is a mix of institutional, retail, and individual investors. Approximately 34.80% of the company’s stock is owned by Institutional Investors, 59.67% is owned by Insiders, and 5.53% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 03, 2026 | xxxxxxxxxxxxx | $65596 | |
May 27, 2026 | xxxxxxxxxxxxx | $65616 | |
May 27, 2026 | xxxxxxxxxxxxx | $65631 | |
May 27, 2026 | xxxxxxxxxxxxx | $65635 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $1477479502 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $46030944 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 51,641,269 | Insider | 47.07% | 13,984,455,645 | |
| 9,560,814 | Insider | 8.71% | 2,589,068,431 | |
| 8,962,461 | Insider | 8.17% | 2,427,034,439 | |
| 8,799,053 | Institution | 8.02% | 2,382,783,552 | |
| 4,975,181 | Institution | 4.53% | 1,347,279,015 | |
| 2,663,960 | Institution | 2.43% | 721,400,368 | |
| 2,319,622 | Institution | 2.11% | 628,153,638 | |
| 2,221,024 | Insider | 2.02% | 601,453,299 | |
| 1,258,504 | Institution | 1.15% | 340,802,883 | |
| 1,232,889 | Insider | 1.12% | 333,866,341 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,663,960 | Institution | 2.43% | 721,400,368 | |
| 2,319,622 | Institution | 2.11% | 628,153,638 | |
| 1,258,504 | Institution | 1.15% | 340,802,883 | |
| 1,169,571 | Institution | 1.07% | 316,719,827 | |
| 1,028,679 | Institution | 0.94% | 278,566,273 | |
| 957,375 | Institution | 0.87% | 259,257,150 | |
| 730,386 | Institution | 0.67% | 197,788,529 | |
| 662,549 | Institution | 0.60% | 179,418,269 | |
| 649,336 | Institution | 0.59% | 175,840,189 | |
| 374,007 | Institution | 0.34% | 101,281,096 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 516,893 | Institution | 0.47% | 139,974,624 | |
| 249,459 | Institution | 0.23% | 67,553,497 | |
| 53,646 | Institution | 0.05% | 14,527,337 | |
| 40,029 | Institution | 0.04% | 10,811,833 | |
| 38,888 | Institution | 0.04% | 10,530,870 | |
| 23,595 | Institution | 0.02% | 6,373,010 | |
| 19,369 | Institution | 0.02% | 5,245,125 | |
| 12,025 | Institution | 0.01% | 3,256,370 | |
| 11,745 | Institution | 0.01% | 3,172,325 | |
| 11,267 | Institution | 0.01% | 3,043,217 |
FAQ
Who Owns BeOne Medicines (ONC)?
According to the latest TipRanks data, approximately 21.97% of the company's stock is held by institutional investors, 59.67% is held by insiders, and 5.53% is held by retail investors.
What percentage of BeOne Medicines (ONC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.97% of BeOne Medicines (ONC) stock is held by institutional investors.
What percentage of BeOne Medicines (ONC) stock is held by retail investors?
According to the latest TipRanks data, approximately 5.53% of BeOne Medicines (ONC) stock is held by retail investors.
Who owns the most shares of BeOne Medicines (ONC)?
JOHN OYLER owns the most shares of BeOne Medicines (ONC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.